FTC files suit with ALJ on Horizon/Amgen deal (NASDAQ:HZNP)

June 24, 2023

in Stocks

Reading Time: 2 mins read

Update 8:12pm: Adds FTC filing complaint with ALJ.

The Federal Trade Commission filed its lawsuit with the in-house Administrative Law Judge to block Amgen’s (NASDAQ:AMGN) planned $28 billion acquisition of Horizon Therapeutics (NASDAQ:HZNP). Horizon (HZNP) rose 1.2% in regular trading.

Support authors and subscribe to content

This is premium stuff. Subscribe to read the entire article.

Gain access to all our Premium contents.
More than 100+ articles.

Subscribe Now

Buy Article

Unlock this article and gain permanent access to read it.

Unlock Now

FTC files suit with ALJ on Horizon/Amgen deal (NASDAQ:HZNP)

Related Articles

Why David Einhorn Is Buying CNH, a Cheap Stock ‘No One Cares About’

5 Charts Showing the Immense Market Impact of Trump’s Presidential Win: BofA

Oil Outlook: US Production Boom, Weak China Demand to Lead to Oversupply in 2025

Stock Market Today: Tech Leads Sell-Off As Rate-Cut Odds Fall on Powell

Inflation Outlook: 4 Signs of Re-Inflation Investors Should Watch Out for

Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ Stocks

8 Tax Loopholes to Reduce or Avoid Capital Gains Taxes

5 Signs Economy Is Heading Toward Recession — Putting Stocks at Risk

It’s a Tough Time to Be a Tech Graduate

Navigate Site

Welcome Back!

Retrieve your password

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

FTC files suit with ALJ on Horizon/Amgen deal (NASDAQ:HZNP)

Support authors and subscribe to content

Subscribe

Buy Article

Related Articles

Navigate Site

Follow Us

Welcome Back!

Retrieve your password

Are you sure want to unlock this post?

Are you sure want to cancel subscription?